Published in Virology on September 01, 2002
Whole genome sequencing and evolutionary analysis of human respiratory syncytial virus A and B from Milwaukee, WI 1998-2010. PLoS One (2011) 1.42
Respiratory syncytial virus: virology, reverse genetics, and pathogenesis of disease. Curr Top Microbiol Immunol (2013) 1.01
Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells. J Virol (2015) 0.90
Identification of a single amino acid change in the human respiratory syncytial virus L protein that affects transcriptional termination. J Virol (2003) 0.86
Effects of altering the transcription termination signals of respiratory syncytial virus on viral gene expression and growth in vitro and in vivo. J Virol (2004) 0.83
Transcriptional Regulation in Ebola Virus: Effects of Gene Border Structure and Regulatory Elements on Gene Expression and Polymerase Scanning Behavior. J Virol (2015) 0.75
Structure of the vesicular stomatitis virus nucleoprotein-RNA complex. Science (2006) 3.70
Transcriptional control of the RNA-dependent RNA polymerase of vesicular stomatitis virus. Biochim Biophys Acta (2002) 1.49
Transcription and replication initiate at separate sites on the vesicular stomatitis virus genome. Proc Natl Acad Sci U S A (2002) 1.39
Segment-specific terminal sequences of Bunyamwera bunyavirus regulate genome replication. Virology (2003) 1.38
Bunyamwera bunyavirus RNA synthesis requires cooperation of 3'- and 5'-terminal sequences. J Virol (2004) 1.30
The cytoplasmic tail of the human respiratory syncytial virus F protein plays critical roles in cellular localization of the F protein and infectious progeny production. J Virol (2006) 1.20
Role of the conserved nucleotide mismatch within 3'- and 5'-terminal regions of Bunyamwera virus in signaling transcription. J Virol (2005) 1.17
Identification of the Bunyamwera bunyavirus transcription termination signal. J Gen Virol (2006) 1.08
Fitness analyses of vesicular stomatitis strains with rearranged genomes reveal replicative disadvantages. J Virol (2004) 1.07
Identification of an upstream sequence element required for vesicular stomatitis virus mRNA transcription. J Virol (2002) 1.00
The baculovirus GP64 protein mediates highly stable infectivity of a human respiratory syncytial virus lacking its homologous transmembrane glycoproteins. J Virol (2004) 0.97
Mutations in the C-terminal loop of the nucleocapsid protein affect vesicular stomatitis virus RNA replication and transcription differentially. J Virol (2009) 0.97
Vesicular stomatitis virus glycoprotein is a determinant of pathogenesis in swine, a natural host. J Virol (2003) 0.97
Analysis of a structural homology model of the 2'-O-ribose methyltransferase domain within the vesicular stomatitis virus L protein. Virology (2008) 0.95
The Bunyamwera virus mRNA transcription signal resides within both the 3' and the 5' terminal regions and allows ambisense transcription from a model RNA segment. J Virol (2005) 0.95
Variations in intergenic region sequences of Human respiratory syncytial virus clinical isolates: analysis of effects on transcriptional regulation. Virology (2004) 0.94
Vesicular stomatitis viruses with rearranged genomes have altered invasiveness and neuropathogenesis in mice. J Virol (2003) 0.92
Human respiratory syncytial virus glycoproteins are not required for apical targeting and release from polarized epithelial cells. J Virol (2008) 0.91
S-adenosyl homocysteine-induced hyperpolyadenylation of vesicular stomatitis virus mRNA requires the methyltransferase activity of L protein. J Virol (2008) 0.90
trans-Complementation allows recovery of human respiratory syncytial viruses that are infectious but deficient in cell-to-cell transmission. J Virol (2004) 0.88
The stability of human respiratory syncytial virus is enhanced by incorporation of the baculovirus GP64 protein. Vaccine (2007) 0.88
Importance of hydrogen bond contacts between the N protein and RNA genome of vesicular stomatitis virus in encapsidation and RNA synthesis. J Virol (2009) 0.86
Identification of a single amino acid change in the human respiratory syncytial virus L protein that affects transcriptional termination. J Virol (2003) 0.86
Respiratory syncytial virus and other pneumoviruses: a review of the international symposium--RSV 2003. Virus Res (2004) 0.85
Newly identified phosphorylation site in the vesicular stomatitis virus P protein is required for viral RNA synthesis. J Virol (2013) 0.83
Variations in transcription termination signals of human respiratory syncytial virus clinical isolates affect gene expression. Virology (2003) 0.82
Requirements for Human Respiratory Syncytial Virus Glycoproteins in Assembly and Egress from Infected Cells. Adv Virol (2011) 0.82
Recombinant vesicular stomatitis (Indiana) virus expressing New Jersey and Indiana glycoproteins induces neutralizing antibodies to each serotype in swine, a natural host. Vaccine (2004) 0.82
Selection for gene junction sequences important for VSV transcription. Virology (2008) 0.81
A temperature sensitive VSV identifies L protein residues that affect transcription but not replication. Virology (2009) 0.81
Biological differences between vesicular stomatitis virus Indiana and New Jersey serotype glycoproteins: identification of amino acid residues modulating pH-dependent infectivity. J Virol (2005) 0.80
Helical virus structure: the case of the rhabdovirus bullet. Viruses (2010) 0.79
Second-site mutations selected in transcriptional regulatory sequences compensate for engineered mutations in the vesicular stomatitis virus nucleocapsid protein. J Virol (2012) 0.78